Showing results (31-40 of 46) with videos related to
Sort By:
Pageof 5
Pediatric Research|October 22, 2004
Interleukin (IL)-1 beta in tracheal aspirates from premature infants induces airway epithelial cell IL-8 expression via an NF-kappa B dependent pathwayThomas K Shimotake, Farzana M Izhar, Kandelaria Rumilla, et al.Biorxiv : the Preprint Server for Biology|November 21, 2023
The Host-specific Microbiota is Required for Diet-Specific Metabolic HomeostasisNa Fei, Bingqing Xie, Tyler J Long, et al.Aquaculture Nutrition|October 3, 2025
Preliminary Assessment of Microalgae, <i>Chlorella vulgaris</i>, and Black Soldier Fly, <i>Hermetia illucens</i> Larvae, as a Viable Alternative Feed Combination for Red Hybrid Tilapia, <i>Oreochromis</i> sp. CultureAslah Mohamad, Ina Salwany Md Yasin, Mohamad Azzam-Sayuti, et al.JCO Precision Oncology|March 5, 2026
Clinical Utility of Transcriptomic Signatures to Identify Androgen Receptor and Neuroendocrine Signaling in Prostate CancerYu-Wei Chen, Joanne Xiu, Kelsey Anne Poorman, et al.The Journal of Clinical Investigation|September 15, 2023
Gut microbes and the liver circadian clock partition glucose and lipid metabolismKatya Frazier, Sumeed Manzoor, Katherine Carroll, et al.Future Oncology (London, England)|June 22, 2021
Phase I study protocol: NKTR-255 as monotherapy or combined with daratumumab or rituximab in hematologic malignanciesNina Shah, Miguel-Angel Perales, Cameron J Turtle, et al.JCO Precision Oncology|December 18, 2024
Longitudinal Testing of Circulating Tumor DNA in Patients With Metastatic Renal Cell CarcinomaArnab Basu, Cherry Au, Ajitha Kommalapati, et al.Journal of Kidney Cancer and VHL|September 12, 2025
Long-term Safety and Efficacy of Belzutifan in Von Hippel-Lindau Syndrome: A VHL Coordinating Care Center ExperiencePaulo Siqueira do Amaral, Ricardo Borges Fonseca, Breanne Reisen, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 3, 2025
IK-175, an Oral Aryl Hydrocarbon Receptor Inhibitor, Alone and with Nivolumab in Patients with Advanced Solid Tumors and Urothelial CarcinomaDavid H Aggen, Meredith McKean, Jean H Hoffman-Censits, et al.JCO Precision Oncology|September 24, 2025
Longitudinal Evaluation of Circulating Tumor DNA as a Prognostic Biomarker to Detect Molecular Residual Disease in Germ Cell TumorsRebecca Hassoun, Reuben Ben-David, John P Sfakianos, et al.Pageof 5